Literature DB >> 15623473

EIN and WHO94.

J P A Baak, G L Mutter.   

Abstract

Mesh：

Year:  2005        PMID： 15623473      PMCID： PMC1770545          DOI： 10.1136/jcp.2004.021071

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  29 in total

Review 1.  Histopathology of genetically defined endometrial precancers.

Authors:  G L Mutter
Journal:  Int J Gynecol Pathol       Date:  2000-10       Impact factor: 2.762

2.  Pitfalls in the diagnosis of endometrial neoplasia.

Authors:  B Winkler; S Alvarez; R M Richart; C P Crum
Journal:  Obstet Gynecol       Date:  1984-08       Impact factor: 7.661

3.  Prospective multicenter evaluation of the morphometric D-score for prediction of the outcome of endometrial hyperplasias.

Authors:  J P Baak; A Ørbo; P J van Diest; M Jiwa; P de Bruin; M Broeckaert; W Snijders; P J Boodt; G Fons; C Burger; R H Verheijen; P W Houben; H S The; P Kenemans
Journal:  Am J Surg Pathol       Date:  2001-07       Impact factor: 6.394

4.  Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers.

Authors:  G L Mutter; M C Lin; J T Fitzgerald; J B Kum; J P Baak; J A Lees; L P Weng; C Eng
Journal:  J Natl Cancer Inst       Date:  2000-06-07       Impact factor: 13.506

5.  High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/- mice.

Authors:  V Stambolic; M S Tsao; D Macpherson; A Suzuki; W B Chapman; T W Mak
Journal:  Cancer Res       Date:  2000-07-01       Impact factor: 12.701

6.  Prediction of endometrial carcinoma by subjective endometrial intraepithelial neoplasia diagnosis.

Authors:  Jonathan L Hecht; Tan A Ince; Jan P A Baak; Heather E Baker; Maryann W Ogden; George L Mutter
Journal:  Mod Pathol       Date:  2005-03       Impact factor: 7.842

7.  Nuclear morphometry in the determination of the prognosis of marked atypical endometrial hyperplasia.

Authors:  E W Ausems; J K van der Kamp; J P Baak
Journal:  Int J Gynecol Pathol       Date:  1985       Impact factor: 2.762

8.  The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients.

Authors:  R J Kurman; P F Kaminski; H J Norris
Journal:  Cancer       Date:  1985-07-15       Impact factor: 6.860

9.  Computer-aided application of quantitative microscopy in diagnostic pathology.

Authors:  J P Baak; P H Kurver; M E Boon
Journal:  Pathol Annu       Date:  1982

10.  Architectural and nuclear morphometrical features together are more important prognosticators in endometrial hyperplasias than nuclear morphometrical features alone.

Authors:  J P Baak; J J Nauta; E C Wisse-Brekelmans; P D Bezemer
Journal:  J Pathol       Date:  1988-04       Impact factor: 7.996
View more
  18 in total

1.  Risk of subsequent endometrial carcinoma associated with endometrial intraepithelial neoplasia classification of endometrial biopsies.

Authors:  James V Lacey; George L Mutter; Marisa R Nucci; Brigitte M Ronnett; Olga B Ioffe; Brenda B Rush; Andrew G Glass; Douglas A Richesson; Nilanjan Chatterjee; Bryan Langholz; Mark E Sherman
Journal:  Cancer       Date:  2008-10-15       Impact factor: 6.860

Review 2.  My approach to the interpretation of endometrial biopsies and curettings.

Authors:  W G McCluggage
Journal:  J Clin Pathol       Date:  2006-08       Impact factor: 3.411

3.  Comparison of WHO and endometrial intraepithelial neoplasia classifications in predicting the presence of coexistent malignancy in endometrial hyperplasia.

Authors:  Mehmet Coskun Salman; Alp Usubutun; Kubra Boynukalin; Kunter Yuce
Journal:  J Gynecol Oncol       Date:  2010-06-30       Impact factor: 4.401

Review 4.  Management of endometrial precancers.

Authors:  Cornelia L Trimble; Michael Method; Mario Leitao; Karen Lu; Olga Ioffe; Moss Hampton; Robert Higgins; Richard Zaino; George L Mutter
Journal:  Obstet Gynecol       Date:  2012-11       Impact factor: 7.661

5.  Involution of latent endometrial precancers by hormonal and nonhormonal mechanisms.

Authors:  Ming-Chieh Lin; Kyla A Burkholder; Akila N Viswanathan; Donna Neuberg; George L Mutter
Journal:  Cancer       Date:  2009-05-15       Impact factor: 6.860

Review 6.  The endometrial hyperplasias revisited.

Authors:  Efthimios Sivridis; Alexandra Giatromanolaki
Journal:  Virchows Arch       Date:  2008-08-23       Impact factor: 4.064

7.  Altered PTEN expression; a diagnostic marker for differentiating normal, hyperplastic and neoplastic endometrium.

Authors:  Soheila Sarmadi; Narges Izadi-Mood; Kambiz Sotoudeh; Seyed Mohammad Tavangar
Journal:  Diagn Pathol       Date:  2009-11-25       Impact factor: 2.644

8.  Antioxidant enzymes and lipid peroxidation in endometrium of patients with polyps, myoma, hyperplasia and adenocarcinoma.

Authors:  Snezana Pejić; Ana Todorović; Vesna Stojiljković; Jelena Kasapović; Snezana B Pajović
Journal:  Reprod Biol Endocrinol       Date:  2009-12-23       Impact factor: 5.211

9.  Endometrial biopsy: a karyometric and stereological study.

Authors:  Aiad Abdullah Abdulrazak
Journal:  Acta Inform Med       Date:  2012-06

10.  Reproducibility determination of WHO classification of endometrial hyperplasia/well differentiated adenocarcinoma and comparison with computerized morphometric data in curettage specimens in Iran.

Authors:  Narges Izadi-Mood; Maryam Yarmohammadi; Seyed Ali Ahmadi; Guity Irvanloo; Hayedeh Haeri; Ali Pasha Meysamie; Mahmood Khaniki
Journal:  Diagn Pathol       Date:  2009-03-25       Impact factor: 2.644
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.